Intracellular transport and peptide loading of MHC class II molecules: Regulation by chaperones and motors

Immunological Reviews

Volumn 172, Issue , 1999, Pages 189-208

  Wubbolts, Richard ^a   Neefjes, Jacques ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN PRESENTATION; ARTICLE; CELLULAR IMMUNITY; HUMAN; IMMUNE RESPONSE; INTRACELLULAR TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT;

EID: 0033428751     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1999.tb01366.x     Document Type: Article

References (312)

1. 1. Wolf PR, Ploegh, HL. How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu Rev Cell Dev Biol 1996;11:267-306.
2. 2. Germain RN, Margulies DH. The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol 1993;11:403-450.
3. 3. Pieters J. MHC class II restricted antigen presentation. Curr Opin Immunol 1997;9:89-96.
4. 4. Rammensee HG, Falk K, Rotzschke O. MHC molecules as peptide receptors. Curr Opin Immunol 1993;5:35-44.
5. 5. Townsend A, Bodmer, H. Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol 1989;7:601-624.
6. 6. Rudensky AY, Preston-Hurlburt P, al-Ramadi BK, Rothbard J, Janeway CA Jr. Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs. Nature 1992;359:429-431.
7. 7. Chicz RM, et al. Predominant naturally-processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 1992;358:764-778.
8. 8. Hunt DF, et al. Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science 1992;256:1817-1820.
9. 9. Rotzschke O, Falk K. Origin, structure and motifs of naturally processed MHC class II ligands. Curr Opin Immunol 1994;6:45-51.
10. 10. Germain RN. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994;76:287-299.
11. 11. Cresswell P. Assembly, transport, and function of MHC class II molecules. Annu Rev Immunol 1994;12:259-293.
12. 12. Cosgrove D, et al. Mice lacking MHC class II molecules. Cell 1991;66:1051-1066.
13. 13. Knight SC, Stagg AJ. Antigen-presenting cell types. Curr Opin Immunol 1993;5:374-382.
14. 14. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994;76:241-251.
15. 15. Toes RE, Schoenberger SP, van der Voort EI, Offringa R, Melief CJM. CD40-CD40 ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunity. Semin Immunol 1998;10:443-448.
16. 16. Roake JA, Rao AS, Morris PJ, Larsen CP, Hankins DF, Austyn JM. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J Exp Med 1995;181:2237-2247.
17. 17. Nelson CA, Petzold SJ, Unanue ER. Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell. Nature 1994;371:250-252.
18. 18. Lanzavecchia A, Reid PA, Watts C. Irreversible association of peptides with class II MHC molecules in living cells. Nature 1992;357:249-252.
19. 19. Buus S, Sette A, Colon SM, Jenis DM, Grey HM. Isolation and characterization of antigen-Ia complexes involved in T cell recognition. Cell 1986;47:1071-1077.
20. 20. Valitutti S, Muller S, Cella M, Padovan E, Lanzavecchia A. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 1995;375:148-151.
21. 21. Murthy VL, Stern LJ. The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding. Structure 1997;5:1385-1396.
22. 22. Stern LJ, Wiley DC. The human class II MHC protein HLA-DR1 assembles as empty αβ heterodimers in the absence of antigenic peptide. Cell 1992;68:465-477.
23. 23. Mosyak L, Zaller DM, Wiley DC. The structure of HLA-DM, the peptide exhange catalyst that loads antigen onto class II MHC molecules during antigen presentation. Immunity 1998;9:377-383.
24. 24. Fremont DH, Crawford F, Marrack P, Hendrickson WA, Kappler J. Crystal structure of mouse H2-M. Immunity 1998;9:385-393.
25. 15. Jasanoff A, Wagner G, Wiley DC. Structure of a trimeric domain of the MHC class II-associated chaperonin and targeting protein Ii. EMBO J 1998;17:6812-6818.
26. 26. Stern LJ, et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994;368:215-221.
27. 27. Bell JI, Denny DW Jr, McDevitt HO. Structure and polymorphism of murine and human class II major histocompatibility antigens. Immunol Rev 1985;84:51-71.
28. 28. Tate K, Lee C, Edelman S, Carswell-Crumpton C, Liblau R. Jones PP. Interactions among polymorphic and conserved residues in MHC class II proteins affect MHC-peptide conformation and T cell recognition. Int Immunol 1995;7:747-761.
29. 29. Monaco JJ. Structure and function of genes in the MHC class II region. Curr Opin Immunol 1993;5:17-20.
30. 30. Miller J, Germain RN. Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain. J Exp Med 1986;164:1478-1489.
31. 31. Sekaly RP, Tonnelle C, Strubin M, Mach B, Long EO. Cell surface expression of class II histocompatibility antigens occurs in the absence of the invariant chain. J Exp Med 1986;164:1490-1504.
32. 32. Nijenhuis M, et al. Targeting major histocompatibility complex class II molecules to the cell surface by invariant chain allows antigen presentation upon recycling. Eur J Immunol 1994;24:873-883.
33. 33. Bijlmakers MJ, Benaroch P, Ploegh HL. Assembly of HLA DR1 molecules translated in vitro: binding of peptide in the endoplasmic reticulum precludes association with invariant chain. EMBO J 1994;13:2699-2707.
34. 34. Hedley ML, Urban RG, Strominger JL. Assembly and peptide binding of major histocompatibility complex class II heterodimers in an in vitro translation system. Proc Natl Acad Sci USA 1994;91:10479-10483.
35. 35. Sung E, Jones PP. The invariant chain of murine Ia antigens: its glycosylation, abundance and subcellular localization. Mol Immunol 1981;18:899-913.
36. 36. Machamer CE, Cresswell P. Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens. J Immunol 1982;129:2564-2569.
37. 37. Kvist S, Wiman K, Claesson L, Peterson PA, Dobberstein B. Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens. Cell 1982;29:61-69.
38. 38. Strubin M, Berte C, Mach B. Alternative splicing and alternative initiation of translation explain the four forms of the Ia antigen-associated invariant chain. EMBO J 1986;5:3483-3488.
39. 39. Claesson L, Larhammar D, Rask L, Peterson PA. cDNA clone for the human invariant γ chain of class II histocompatibility antigens and its implications for the protein structure. Proc Natl Acad Sci USA 1983;80:7395-7399.
40. 40. Sam AJ, Miller J. MHC class II antigen processing: biology of invariant chain. Curr Opin Immunol 1994;6:57-63.
41. 41. Bonnerot C, et al. Association with BiP and aggregation of class II MHC molecules synthesized in the absence of invariant chain. EMBO J 1994;13:934-944.
42. 42. Nijenhuis M, Neefjes J. Early events in the assembly of major histocompatibility complex class II heterotrimers from their free subunits. Eur J Immunol 1994;24:247-256.
43. 43. Cotner T, Pious D. HLA-DR β chains enter into an aggregated complex containing GRP-78/BiP prior to their degradation by the pre-Golgi degradative pathway. J Biol Chem 1995;270:2379-2386.
44. 44. Schaiff WT, Hruska KA Jr, McCourt DW, Green M, Schwanz BD. HLA-DR associates with specific stress proteins and is retained in the endoplasmic reticulum in invariant chain negative cells. J Exp Med 1992;176:657-666.
45. 45. Schreiber KL, et al. Class II histocompatibility molecules associate with calnexin during assembly in the endoplasmic reticulum. Int Immunol 1994;6:101-111.
46. 46. Anderson KS, Cresswell P. A role for calnexin (IP90) in the assembly of class II MHC molecules. EMBO J 1994;13:675-682.
47. 47. Lipp J, Dobberstein B. Signal and membrane anchor functions overlap in the type II membrane protein I γ CAT. J Cell Biol 1988;106:1813-1820.
48. 48. O'Sullivan DM, Noonan D, Quaranta V. Four Ia invariant chain forms derive from a single gene by alternate splicing and alternate initiation of transcription/translation. J Exp Med 1987;166:444-460.
49. 49. Koch N, Lauer W, Habicht J, Dobberstein B. Primary structure of the gene for the murine Ia antigen-associated invariant chains (Ii). An alternatively spliced exon encodes a cysteine-rich domain highly homologous to a repetitive sequence of thyroglobulin. EMBO J 1987;6:1677-1683.
50. 50. McKnight AJ, Mason DW. Barclay AN. Sequence of a rat MHC class II-associated invariant chain cDNA clone containing a 64 amino acid thyroglobulin-like domain. Nucleic Acids Res 1989;17:3983-3994.
51. 51. Koch N. Posttranslational modifications of the Ia-associated invariant protein p41 after gene transfer. Biochemistry 1988;27:4097-4102.
52. 52. Cresswell P. Chemistry and functional role of the invariant chain. Curr Opin Immunol 1992;4:87-92.
53. 53. Lamb CA, Cresswell P. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes. J Immunol 1992;148:3478-3482.
54. 54. Marks MS, Blum JS, Cresswell P. Invariant chain trimers are sequestered in the rough endoplasmic reticulum in the absence of association with HLA class II antigens. J Cell Biol 1990;111:839-855.
55. 55. Bijlmakers MJ, Benaroch P, Ploegh HL. Mapping functional regions in the lumenal domain of the class II-associated invariant chain. J Exp Med 1994;180:623-629.
56. 56. Bertolino P, et al. Deletion of a C-terminal sequence of the class II-associated invariant chain abrogates invariant chains oligomer formation and class II antigen presentation. J Immunol 1995;154:5620-5629.
57. 57. Arunachalam B, Lamb CA, Cresswell P. Transport properties of free and MHC class II-associated oligomers containing different isoforms of human invariant chain. Int Immunol 1994;6:439-451.
58. 58. Roche PA, Marks MS, Cresswell P. Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature 1991;354:392-394.
59. 59. Sette A, et al. Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. Science 1992;258:1801-1804.
60. 60. Riberdy JM, Newcomb JR, Surman MJ, Barbosa JA, Cresswell P. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature 1992;360:474-477.
61. 61. Romagnoli P, Germain RN. The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy. J Exp Med 1994;180:1107-1113.
62. 62. Ghosh P, Amaya M, Mellins E, Wiley DC. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 1995;378:457-462.
63. 63. Teyton L, et al. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways Nature 1990;348:39-44.
64. 64. Schutze MP, Peterson PA, Jackson MR. An N-terminal double-arginine motif maintains type II membrane proteins in the endoplasmic reticulum. EMBO J 1994;13:1696-1705.
65. 65. Pieters J, Bakke O, Dobberstein B. The MHC class II-associated invariant chain contains two endosomal targeting signals within its cytoplasmic tail. J Cell Sci 1993;106:831-846.
66. 66. Bremnes B, Madsen T, Gedde-Dahl M, Bakke O. An LI and ML motif in the cytoplasmic tail of the MHC-associated invariant chain mediate rapid internalization. J Cell Sci 1994;107:2021-2032.
67. 67. Bakke O, Dobberstein B. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 1990;63:707-716.
68. 68. Odorizzi CG, et al. Sorting signals in the MHC class II invariant chain cytoplasmic tail and transmembrane region determine trafficking to an endocytic processing compartment. J Cell Biol 1994;126:317-330.
69. 69. Lotteau V, et al. Intracellular transport of class II MHC molecules directed by invariant chain. Nature 1990;348:600-605.
70. 70. Loss GE Jr, Sant AJ. Invariant chain retains MHC class II molecules in the endocytic pathway. J Immunol 1993;150:3187-3197.
71. 71. Lamb CA, Yewdell JW, Bennink JR, Cresswell P. Invariant chain targets HLA class II molecules to acidic endosomes containing internalized influenza virus. Proc Natl Acad Sci USA 1991;88:5998-6002.
72. 72. Neefjes JJ, Stollorz V, Peters PJ, Geuze HJ, Ploegh HL. The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell 1990;61:171-183.
73. 73. Kang S, Liang L, Parker CD, Collawn JF. Structural requirements for major histocompatibility complex class II invariant chain endocytosis and lysosomal targeting. J Biol Chem 1998;273:20644-20652.
74. 74. Chervonsky AV, Gordon L, Sant AJ. A segment of the MHC class II β chain plays a critical role in targeting class II molecules to the endocytic pathway. Int Immunol 1994;6:973-982.
75. 75. Pinet V, Vergelli M, Martin R, Bakke O, Long EO. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature 1995;375:603-606.
76. 76. Geuze HJ. The role of endosomes and lysosomes in MHC class II functioning. Immunol Today 1998;19:282-287.
77. 77. Neefjes J. CIIV, MIIC and other compartments for MHC class II loading. Eur J Immunol 1999;29:1421-1425.
78. 78. Peters PJ, Neefjes JJ, Oorschot V, Ploegh HL, Geuze HJ. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 1991;349:669-676.
79. 79. Neefjes JJ, Ploegh HL. Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistance αβ heterodimers in endosomes. EMBO J 1992;11:411-416.
80. 80. Reid PA, Watts C. Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments. Nature 1990;346:655-657.
81. 81. Roche PA, et al. Stable surface expression of invariant chain prevents peptide presentation by HLA-DR. EMBO J 1992;11:2841-2847.
82. 82. Henne C, Schwenk F, Koch N, Moller P. Surface expression of the invariant chain (CD74) is independent on concomitant expression of major histocompatibility complex class II antigens. Immunology 1995;84:177-182.
83. 83. Warmerdam PA, Long EO, Roche PA. Isoforms of the invariant chain regulate transport of MHC class II molecules to antigen processing compartments. J Cell Biol 1996;133:281-291.
84. + T cell selection in mice lacking invariant chain expression. J Exp Med 1993;177:1699-1712.
85. 85. Elliott EA, et al. The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules. J Exp Med 1994;179:681-694.
86. 86. Viville S, et al. Mice lacking the MHC class II-associated invariant chain. Cell 1993;72:635-648.
87. 87. Bikoff EK, Germain RN, Robertson EJ. Allelic differences affecting invariant chain dependency of MHC class II subunit assembly. Immunity 1995;2:301-310.
88. 88. Stockinger B, Pessara U, Lin RH, Habicht J, Grez M, Koch N. A role of Ia-associated invariant chains in antigen processing and presentation. Cell 1989;56:683-689.
89. 89. Anderson MS, Swier K, Arneson L, Miller J. Enhanced antigen presentation in the absence of the invariant chain endosomal localization signal. J Exp Med 1993;178:1959-1969.
90. 90. Peterson M, Miller J. Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41. Nature 1992;357:596-598.
91. 91. Naujokas MF, Morin M, Anderson MS, Peterson M, Miller J. The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell 1993;74:257-268.
92. 92. Van Noort JM, Jacobs MJM. Cathepsin D, but not cathepsin B, releases T cell stimulatory fragments from lysozyme that are functional in the context of multiple murine class II MHC molecules. Eur J Immunol 1994;24:2175-2180.
93. 93. Rodriguez GM, Diment S. Destructive proteolysis by cysteine proteases in antigen presentation of ovoalbumin. Eur J Immunol 1995;25:1823-1827.
94. 94. Deussing J, et al. Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation. Proc Natl Acad Sci USA 1998;95:4516-4521.
95. 95. Nakagawa T, et al. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 1998;280:450-453.
96. 96. Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Immunol 1997;15:821-850.
97. 97. Lanzavecchia, A. Mechanisms of antigen uptake for presentation. Curr Opin Immunol 1996;8:348-354.
98. 98. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995;182:389-400.
99. 99. Jiang W, et al. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 1995;375:151-155.
100. 100. Amigorena S, Bonnerot C. Role of B-cell and Fc receptors in the selection of T-cell epitopes. Curr Opin Immunol 1998;10:88-92.
101. 101. Watts C, Lanzavecchia A. Suppressive effect of antibody on processing of T cell epitopes. J Exp Med 1993;178:1459-1463.
102. 102. Jacquier-Sarlin MR, Gabert FM, Villiers MB, Colomb MG. Modulation of antigen processing and presentation by covalently linked complement C3b fragment. Immunology 1995;84:164-170.
103. 103. Cristau B, Schafer PH, Pierce SK. Heat shock enhances antigen processing and accelerates the formation of compact class II αβ dimers. J Immunol 1994;152:1546-1556.
104. 104. Roche PA, Cresswell P. Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc Natl Acad Sci USA 1991;88:3150-3154.
105. 105. Germain RN, Hendrix LR. MHC class II structure, occupancy, and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 1991;353:134-139.
106. 106. Maric MA, Taylor MD, Blum JS. Endosomal aspartic proteinases are required for invariant-chain processing. Proc Natl Acad Sci USA 1994;91:2171-2175.
107. 107. Pieters J, Horstmann H, Bakke O, Griffiths G, Lipp J. Intracellular transport and localization of major histocompatibility complex class II molecules and associated invariant chain. J Cell Biol 1991;115:1213-1223.
108. 108. Blum JS, Cresswell P. Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc Natl Acad Sci USA 1988;85:3975-3979.
109. 109. Stebbins CC, Loss GE Jr, Elias CG, Chervonsky A, Sane AJ. The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent. J Exp Med 1995;181-223-234.
110. 110. Villadangos JA, Riese RJ, Peters C, Chapman HA, Ploegh HL. Degradation of mouse invariant chain: roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism. J Exp Med 1997;186:549-560.
111. 111. Riese RJ, et al. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 1996;4:357-366.
112. 112. Riese RJ, et al. Cathepsin S activity regulates antigen presentation and immunity. J Clin Invest 1998;101:2351-2363.
113. 113. Shi GP, et al. Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity 1999;10:197-206.
114. 114. Nakagawa TY, et al. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity 1999;10:207-217.
115. 115. Chapman HA. Endosomal proteolysis and MHC class II function. Curr Opin Immunol 1998;10:93-102.
116. 116. Ogrinc T, Dolenc I, Ritonja A, Turk V. Purification of the complex of cathepsin L and the MHC class II-associated invariant chain fragment from human kidney. FEBS Lett 1993;336:555-559.
117. 117. Guncar G, Pungercic G, Klemencic I, Turk V, Turk D. Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S. EMBO J 1999;18:793-803.
118. 118. Bevec T, Stoka V, Pungercic G, Dolenc I, Turk V. Major histocompacibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L. J Exp Med 1996;183:1331-1338.
119. 119. Katunuma N, Kakegawa H, Matsunaga Y, Saibara T. Immunological significances of invariant chain from the aspect of its structural homology with the cystatin family. FEBS Lett 1994;349:265-269.
120. 120. Fineschi B, Sakaguchi K, Appella E, Miller J. The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain. J Immunol 1996;157:3211-3215.
121. + T cell function in mice lacking the p41 isoform of invariant chain. Immunity 1995;3:385-396.
122. + T cell development. Immunity 1995;3:359-372.
123. 123. Mellins E, Smith L, Arp B, Cotner T, Celis E, Pious D. Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes. Nature 1990;343:71-76.
124. 124. Fling SP, Arp B, Pious D. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells Nature 1994;368;554-558.
125. 125. Morris P, et al. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 1994;368:551-554.
126. 126. Mellins E, Kempin S, Smith L, Monji T, Pious D. A gene required for class II-restricted antigen presentation maps to the major histocompatibility complex. J Exp Med 1991;174:1607-1615.
127. 127. Mellins E, et al. A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides. J Exp Med 1994;179:541-549.
128. 128. Denzin LK, Robbins NF, Carboy-Newcomb C, Cresswell P. Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells. Immunity 1994;1:595-606.
129. 129. Cho SG, Attaya M, Monaco JJ. New class II-like genes in the murine MHC. Nature 1991;353:573-576.
130. 130. Lindstedt R, Liljedahl M, Peleraux A, Peterson PA, Karlsson L. The MHC class II molecule H2-M is targeted to an endosomal compartment by a tyrosine-based targeting motif. Immunity 1995;3:561-572.
131. 131. Copier J, et al. Targeting signal and subcellular compartments involved in the intracellular trafficking of HLA-DMB. J Immunol 1996;157:1017-1027.
132. 132. Marks MS, Roche PA, van Donselaar E, Woodruff L, Peters PJ, Bonifacino JS. A lysosomal targeting signal in the cytoplasmic tail of the β chain directs HLA-DM to MHC class II compartments. J Cell Biol 1995;131:351-369.
133. 133. Liu SH, Marks MS, Brodsky FM. A dominant-negative clathrin mutant differentially affects trafficking of molecules with distinct sorting motifs in the class II major histocompatibility complex (MHC) pathway. J Cell Biol 1998;140:1023-1037.
134. 134. Sloan VS, et al. Mediation by HLA-DM of dissociation of peptides from HLA-DR Nature 1995;375:802-806.
135. 135. Denzin LK, Cresswell P. HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 1995;82:155-166.
136. 136. Sherman MA, Weber DA, Jensen PE. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 1995;3:197-205.
137. 137. Vogt AB, Kropshofer H, Moldenhauer G, Hammerling GJ. Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM. Proc Natl Acad Sci USA 1996;93:9724-9729.
138. 138. Kropshofer H, Arndt SO, Moldenhauer G, Hammerling GJ, Vogt AB. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunity 1997;6:293-302.
139. 139. Sanderson F, Thomas C, Neefjes J, Trowsdale J. Association between HLA-DM and HLA-DR in vivo. Immunity 1996;4:87-96.
140. 140. Denzin LK, Hammond C, Cresswell P. HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J Exp Med 1996;184:2153-2165.
141. 141. Van Ham SM, et al. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading. Curr Biol 1997;7:950-957.
142. 142. Vogt AB, Moldenhauer G, Hämmerling GJ, Kropshofer H. HLA-DM stabilizes empty HLA-DR molecules in a chaperone-like fashion. Immunol Lett 1997;57:209-211.
143. 143. Guerra CB, et al. Novel glycosylation of HLA-DRα disrupts antigen presentation without altering endosomal localization. J Immunol 1998;160:4289-4297.
144. 144. Ullrich HJ, Doring K, Gruneberg U, Jahnig F, Trowsdale J, van Ham SM. Interaction between HLA-DM and HLA-DR involves regions that undergo conformational changes at lysosomal pH. Proc Natl Acad Sci USA 1997;94:13163-13168.
145. 145. Martin WD, et al. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell 1996;84:543-550.
146. 146. Miyazaki T, et al. Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell 1996;84:531-541.
147. 147. Fung-Leung WP, et al. Antigen presentation and T cell development in H2-M-deficient mice. Science 1996;271:1278-1281.
148. 148. Kovats S, Whiteley PE, Concannon P, Rudensky AY, Blum JS. Presentation of abundant endogenous class II DR-restricted antigens by DM-negative B cell lines. Eur J Immunol 1997;27:1014-1021.
149. 149. Bikoff EK, Kenty G, van Kaer L. Distinct peptide loading pathways for MHC class II molecules associated with alternative Ii chain isoforms. J Immunol 1998;160:3101-3110.
150. 150. Tonnelle C, DeMars R, Long EO. DO β: a new β chain gene in HLA-D with a distinct regulation of expression. EMBO J 1985;4:2839-2847.
151. 151. Liljedahl M, et al. HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport. EMBO J 1996;15:4817-4824.
152. 152. Denzin LK, Sant'Angelo DB, Hammond C, Surman MJ, Cresswell P. Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science 1997;278:106-109.
153. 153. Jensen PE. Antigen processing: HLA-DO -a hitchhiking inhibitor of HLA-DM Curr Biol 1998;8:128-131.
154. 154. Karlsson L, Surh CD, Sprent J, Peterson PA. A novel class II MHC molecule with unusual tissue distribution. Nature 1991;351:485-488.
155. 155. Karlsson L, Peterson PA. The α chain gene of H-20 has an unexpected location in the major histocompatibility complex. J Exp Med 1992;176:477-483.
156. 156. Surh CD, et al. Two subsets of epithelial cells in the thymic medulla. J Exp Med 1992;176:495-505.
157. 157. Liljedahl M, et al. Altered antigen presentation in mice lacking H2-O. Immunity 1998;8:233-243.
158. 158. Kropshofer H, et al. A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules. EMBO J 1998;17:2971-2981.
159. 159. Pinet VM, Long EO. Peptide loading onto recycling HLA-DR molecules occurs in early endosomes. Eur J Immunol 1998;28:799-804.
160. 160. Zachgo S, Dobberstein B, Griffiths G. A block in degradation of MHC class II-associated invariant chain correlates with a reduction in transport from endosome carrier vesicles to the prelysosome compartment. J Cell Sci 1992;103:811-822.
161. 161. Harding CV, Geuze HJ. Class II MHC molecules are present in macrophage lysosomes and phagolysosomes that function in the phagocytic processing of Listeria monocytogenes for presentation to T cells. J Cell Biol 1992;119:531-542.
162. 162. West MA, Lucocq JM, Watts C. Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells. Nature 1994;369:147-151.
163. 163. Peters PJ, et al. Major histocompatibility complex class II compartments in human B lymphoblastoid cells are distinct from early endosomes. J Exp Med 1995;182:325-334.
164. 164. Kleijmeer MJ, Morkowski S, Griffith JM, Rudensky AY, Geuze HJ. Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments. J Cell Biol 1997;139:639-649.
165. 165. Fernandez-Borja M, et al. HLA-DM and MHC class II molecules co-distribute with peptidase-containing lysosomal subcompartments. Int Immunol 1996;8:625-640.
166. 166. Karlsson L, Peleraux A, Lindstedt R, Liljedahl M, Peterson PA. Reconstitution of an operational MHC class II compartment in nonantigen-presenting cells. Science 1994;266:1569-1573.
167. 167. Sanderson F, etal. Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science 1994;266:1566-1569.
168. 168. Riberdy JM, Awa RR, Geuze HJ, Cresswell P. Transport and intracellular distribution of MHC class II molecules and associated invariant chain in normal and antigen-processing mutant cell lines. J Cell Biol 1994;125:1225-1237.
169. 169. Nijman HW, et al. Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells. J Exp Med 1995;182.163-174.
170. 170. Fernandez-Borja M, et al. Mutilvesicular body morphogenesis requires phosphatidyl-inositol 3-kinase activity. Curr Biol 1998;125:55-58.
171. 171. Harding CV, Geuze HJ. Immunogenic peptides bind to class II MHC molecules in an early lysosomal compartment. J Immunol 1993;151:3988-3998.
172. 172. Amigorena S, Drake JR, Webster P, Mellman I. Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature 1994;369:113-120.
173. 173. Amigorena S, Webster P, Drake J, Newcomb J, Cresswell P, Mellman I. Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles. J Exp Med 1995;181:1729-1741.
174. 174. Pierre P, et al. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 1997;388:787-792.
175. 175. Pierre P, et al. HLA-DM is localized to conventional and unconventional MHC class II-containing endocytic compartments. Immunity 1996;4:229-239.
176. 176. Raposo G, et al. B-lymphocytes secrete antigen processing vesicles. J Exp Med 1996;183:1161-1172.
177. 177. Wubbolts RW, et al. Direct vesicular transport of MHC class II molecules from lysosomal structures to the cell surface. J Cell Biol 1996;135:611-622.
178. 178. Qiu Y, Xu X, Wandinger-Ness A, Dalke DP, Pierce SK. Separation of subcellular compartments containing distinct functional forms of MHC class II. J Cell Biol 1994;115:595-605.
179. 179. Tulp A, Verwoerd D, Dobberstein B, Ploegh HL, Pieters J. Isolation and characterization of the intracellular MHC class II compartment. Nature 1994;369:120-126.
180. 180. Morkowski S, Raposo G, Kleijimeer M, Geuze HJ, Rudensky AY. Assembly of an abundant endogenous major histocompatibility complex class II/peptide complex in class II compartments. Eur J Immunol 1997;27:609-617.
181. 181. Harding CV, Collins DS, Slot JW, Geuze HJ, Unanue ER. Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells. Cell 1991;64:393-401.
182. 182. Castellino F, Germain RN. Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments. Immunity 1995;2:73-88.
183. 183. Barnes KA, Mitchell RN. Detection of functional class II-associated antigen: role of a low density endosomal compartment in antigen processing. J Exp Med 1995;181:1715-1727.
184. 184. Roche PA, Teletski CL, Stang E, Baue O, Long EO. Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization. Proc Natl Acad Sci USA 1993;90:8581-8585.
185. 185. Schafer PH, Green JM, Malapati S, Gu L, Pierce SK. HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes. J Immunol 1996;157:5487-5495.
186. 186. Stang E, Guerra CB, Amaya M, Paterson Y, Bakke O, Mellins ED. DR/CLIP (class II-associated invariant chain peptides) and DR/peptide complexes colocalize in prelysosomes in human B lymphoblastoid cells. J Immunol 1998;160:4696-4707.
187. 187. Robbins NF, Hammond C, Denzin LK, Pan M, Cresswell P. Trafficking of major histocompatibility complex class II molecules through intracellular compartments containing HLA-DM. Hum Immunol 1996;45:13-23.
188. 188. Reid PA, Watts C. Constitutive endocytosis and recycling of major histocompatibility complex class II glycoproteins in human B-lymphoblastoid cells. Immunology 1992;77:539-542.
189. 189. Salamero J, Humbert M, Cosson P, Davoust J. Mouse B lymphocyte specific endocytosis and recycling of MHC class II molecules. EMBO J 1990;9:3489-3496.
190. 190. Pinet V, Malnati MS, Long EO. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen. J Immunol 1994;152:4851-4860.
191. 191. Ma C, Blum JS. Receptor-mediated endocytosis of antigens overcomes the requirement for HLA-DM in class II-restricted antigen presentation. J Immunol 1997;158:1-4.
192. 192. Calafat J, et al. Major histocompatibility complex class II molecules induce the formation of endocytic MIIC-like structures. J Cell Biol 1994;126:967-977.
193. 193. Arkema JM, Schadee-Eestermans IL, Broekhuis-Fluitsma DM, Hoefsmit EC. Localization of class II molecules in storage vesicles, endosomes and lysosomes in human dendritic cells. Immunobiology 1991;183:396-407.
194. 194. Stossel H, et al. Disappearance of certain acidic organelles (endosomes and Langerhans cell granules) accompanies loss of antigen processing capacity upon culture of epidermal Langerhans cells. J Exp Med 1990;172:1471-1482.
195. 195. Kleijmeer MJ, Oorschot VM, Geuze HJ. Human resident Langerhans cells display a lysosomal compartment enriched in MHC class II. J Invest Dermatol 1994;103:516-523.
196. 196. Talmor M, Mirza A, Turley S. Mellman I, Hoffman LA, Steinman RM, Generation or large numbers of immature and mature dendritic cells from rat bone marrow cultures. Eur J Immunol 1998;28:811-817.
197. 197. Pierre P, Mellman I. Exploring the mechanisms of antigen processing by cell fractionation. Curr Opin Immunol 1998;10:145-153.
198. 198. De Camilli P, Emr SD, McPherson PS, Novick P. Phosphoinositides as regulators in membrane traffic. Science 1996;271:1533-1539.
199. 199. Peterson MR, Burd CG, Emr SD. Vac1p coordinates rab and phosphatidylinositol 3-kinase signaling in Vps45p-dependent vesicle docking/fusion at the endosome. Curr Biol 1999;9:159-162.
200. 200. Wurmser AE, Emr SD. Phosphoinositide signalling and turnover: PtdIns(3)P, a regulator of membrane traffic, is transported to the vacuole and degraded by a process that requires luminal vacuolar hydrolase activities. EMBO J 1998;17:4930-4942.
201. 201. Escola J-M, Kleijmeer MJ, Stoorvogel W, Griffith JM, Yoshie O, Geuze HJ. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B lymphocytes. J Biol Chem 1998;273:20121-20127.
202. 202. Hammond C, Denzin LK, Pan M, Griffith JM, Geuze HJ, Cresswell P. The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules. J Immunol 1998;161:3282-3291.
203. 203. Kobayashi T, Stang E, Fang KS, de Moederloose P, Parton RG, Gruenberg J. A lipid associated with the antiphospholipid syndrome regulates endosome structure and function. Nature 1998;392:193-197.
204. 204. Pond L, Watts C. Characterization of transport of newly assembled, T cell-stimulatory MHC class II-peptide complexes from MHC class II compartments to the cell surface. J Immunol 1997;159:543-553.
205. 205. Pierre P, Mellman I. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 1998;93:1135-1145.
206. 206. Koppelman B, Neefjes J, de Vries JE, de Waal Malefyt R. Interleukin-10 down-regulates MHC class II ab peptide complexes at the plasma membrane of monocyte by affecting arrival and recycling. Immunity 1997;7:861-871.
207. Z07. Svitkina TM, Verkhovsky AB, Borisy GG. Plectin sidearms mediate interaction of intermediate filaments with microtubules and other components of the cytoskeleton. J Cell Biol 1996;135:991-1007.
208. 208. Wade RH, Hyman AA. Microtubule structure and dynamics. Curr Opin Cell Biol 1997;9:12-17.
209. 209. Vale RD, Reese TS, Sheetz MP. Identification of a novel force-generating protein, kinesin, involved in microtubule-based motility. Cell 1985;42:39-50.
210. 210. Vale RD, Schnapp BJ, Mitchison T, Steuer E, Reese TS, Sheetz, MP. Different axoplasmic proteins generate movement in opposite directions along microtubules in vitro. Cell 1985;43:623-632.
211. 211. Paschal BM, Vallee RB. Retrograde transport by the microtubule-associated protein MAP 1C. Nature 1987;330:181-183.
212. 212. Hirokawa N. Kinesin and dynein superfamily proteins and the mechanism of organelle transport. Science 1998;279:519-526.
213. 213. Case RB, Pierce DW, Hom-Booher N, Hart CL, Vale RD. The directional preference of kinesin motors is specified by an element outside of the motor catalytic domain. Cell 1997;90:959-966.
214. 214. Goodson HV, Valetti C, Kreis TE. Motors and membrane traffic. Curr Opin Cell Biol 1997;9:18-28.
215. 215. Vale RD, Hotani H. Formation of membrane networks in vitro by kinesin-driven microtubule movement. J Cell Biol 1988;107:2233-2241.
216. 216. Lippincott-Schwartz J, Cole NB, Marotta A, Conrad PA, Bloom GS. Kinesin is the motor for microtubule-mediated Golgi-to-ER membrane traffic. J Cell Biol 1995;128:293-306.
217. 217. Feiguin, F, Ferreira A, Kosik KS, Caceres A. Kinesin-mediated organelle translocation revealed by specific cellular manipulations. J Cell Biol 1994;127:1021-1039.
218. 218. Burkhardt, JK, McIlvain JM Jr, Sheetz MP, Argon Y. Lytic granules from cytotoxic T cells exhibit kinesin-dependent motility on microtubules in vitro. J Cell Sci 1993;104:151-162.
219. 219. Schmitz F, Wallis KT, Rho M, Drenckhahn D, Murphy DB. Intracellular distribution of kinesin in chromaffin cells. Eur J Cell Biol 1994;63:77-83.
220. 220. Rodriguez A, Samoff E, Rioult MG, Chung A, Andrews NW. Host cell invasion by trypanosomes requires lysosomes and microtubule/kinesin-mediated transport. J Cell Biol 1996;134:349-362.
221. 221. Hollenbeck PJ, Swanson JA. Radial extension of macrophage tubular lysosomes supported by kinesin. Nature 1990;346:864-866.
222. 222. Nakata T, Hirokawa N. Point mutation of adenosine triphosphate-binding motif generated rigor kinesin that selectively blocks anterograde lysosome membrane transport. J Cell Biol 1995;131:1039-1053.
223. 223. Blocker A, et al. Molecular requirements for bi-directional movement of phagosomes along microtubules. J Cell Biol 1997;137:113-129.
224. 224. Schnitzer MJ, Block SM. Kinesin hydrolyses one ATP per 8-nm step. Nature 1997;388:386-390.
225. 225. Howard J. The movement of kinesin along microtubules. Annu Rev Physiol 1996;58:703-729.
226. 226. Cyr JL, Pfister KK, Bloom GS, Slaughter CA, Brady ST. Molecular genetics of kinesin light chains: generation of isoforms by alternative splicing. Proc Natl Acad Sci USA 1991;88:10114-10118.
227. 227. Stenoien DL, Brady ST. Immunochemical analysis of kinesin light chain function. Mol Biol Cell 1997;8:675-689.
228. 228. Gindhart JG Jr, Desai CJ, Beushausen S, Zinn K, Goldstein LS. Kinesin light chains are essential for axonal transport in Drosophila. J Cell Biol 1998;141:443-454.
229. 229. Skoufias DA, Cole DG, Wedaman KP, Scholey JM. The carboxyl-terminal domain of kinesin heavy chain is important for membrane binding. J Biol Chem 1994;269:1477-1485.
230. 230. Toyoshima I, Yu H, Steuer ER, Sheetz MP. Kinectin, a major kinesin-binding protein on ER. J Cell Biol 1992;118:1121-1131.
231. 231. Futterer A, Kruppa G, Kramer B, Lemke H, Kronke M. Molecular cloning and characterization of human kinectin. Mol Biol Cell 1995;6:161-170.
232. 132. Leung E, et al. Cloning of novel kinectin splice variants with alternative C-termini: structure, distribution and evolution of mouse kinectin. Immunol Cell Biol 1996;74:421-433.
233. 233. Paschal BM, Shpetner HS, Vallee RB. MAP 1C is a microtubule-activated ATPase which translocates microtubules in vitro and has dynein-like properties. J Cell Biol 1987;105:1273-1282.
234. 234. Shpetner HS, Paschal BM, Vallee RB. Characterization of the microtubule-activated ATPase of brain cytoplasmic dynein (MAP 1C). J Cell Biol 1988;107:1001-1009.
235. 235. Schroer TA, Steuer ER, Sheetz MP. Cytoplasmic dynein is a minus end-directed motor for membranous organelles. Cell 1989;56:937-946.
236. 236. Holzbaur EL, Vallee RB. DYNEINS: molecular structure and cellular function. Annu Rev Cell Biol 1994;10:339-372.
237. 237. Vaisberg EA, Grissom PM, McIntosh JR. Mammalian cells express three distinct dynein heavy chains that are localized to different cytoplasmic organelles. J Cell Biol 1996;133:831-842.
238. 238. Vallee RB, Wall JS, Paschal BM, Shpetner HS. Microtubule-associated protein 1C from brain is a two-headed cytosolic dynein. Nature 1988;332:561-563.
239. 239. Samso M, Radermacher M, Frank J, Koonce MP. Structural characterization of a dynein motor domain. J Mol Biol 1998;276:927-937.
240. 240. Ogawa K. Four ATP-binding sites in the midregion of the β heavy chain of dynein Nature 1991;352:643-645.
241. 241. Gee MA, Heuser JE, Vallee RB. An extending microtubule-binding structure within the dynein binding domain. Nature 1998;390:636-639.
242. 242. Paschal BM, Mikami A, Pfister KK, Vallee RB. Homology of the 74-kD cytoplasmic dynein subunit with a flagellar dynein polypeptide suggests an intracellular targeting function. J Cell Biol 1992;118:1133-1143.
243. 243. Gill SR, Cleveland DW, Schroer TA. Characterization of DLC-A and DLC-B, two families of cytoplasmic dynein light chain subunits. Mol Biol Cell 1994;5:645-654.
244. 244. Hughes SM, Vaughan KT, Herskovits JS, Vallee RB. Molecular analysis of a cytoplasmic dynein light intermediate chain reveals homology to a family of ATPases. J Cell Sci 1995;108:17-24.
245. 245. King, SM, Dillman JF III, Benashski SE, Lye RJ, Patel-King RS, Pfister KK. The mouse t-complex-encoded protein Tctex-1 is a light chain of brain cytoplasmic dynein. J Biol Chem 1996;271:32281-32287.
246. 246. King SM, Barbarese E, Dillman JF III, Patel-King RS, Carson JH, Pfister KK. Brain cytoplasmic and flagellar outer arm dynamics share a highly conserved Mr 8,000 light chain. J Biol Chem 1996;271:19358-19366.
247. 247. Lacey ML, Haimo LT. Cytoplasmic dynein is a vesicle protein. J Biol Chem 1992;267:4793-4798.
248. 248. Lacey ML, Haimo LT. Cytoplasmic dynein binds to phospholipid vesicles. Cell Motil Cytoskeleton 1994;28:205-212.
249. 249. Muresan V, Godek CP, Reese TS, Schnapp BJ. Plus-end motors override minus-end motors during transport of squid axon vesicles on microtubules. J Cell Biol 1996;135:383-397.
250. 250. Schroer TA, Sheetz MP. Two activators of microtubule-based vesicle transport. J Cell Biol 1991;115:1309-1318.
251. 251. Paschal BM, Holzbaur EL, Pfister KK, Clark S, Meyer DI, Vallee RB. Characterization of a 50-kDa polypeptide in cytoplasmic dynein preparations reveals a complex with p1 50GLUED and a novel actin. J Biol Chem 1993;268:15318-15323.
252. 252. Holzbaur EL, Hammarback JA, Paschal BM, Kravit NG, Pfister KK, Vallee RB. Homology of a 150K cytoplasmic dynein-associated polypeptide with the Drosophila gene Glued. Nature 1991;351:579-583.
253. 253. King SM, Witman GB. Localization of an intermediate chain of outer arm dynein by immunoelectron microscopy. J Biol Chem 1990;265:19807-19811.
254. 254. Karki S, Holzbaur EL. Affinity chromatography demonstrates a direct binding between cytoplasmic dynein and the dynactin complex. J Biol Chem 1995;270:28806-28811.
255. 255. Vaughan KT, Vallee RB. Cytoplasmic dynein binds dynactin through a direct interaction between the intermediate chains and p1 50Glued. J Cell Biol 1995;131:1507-1516.
256. 256. Waterman-Storer CM, Karki S, Holzbaur EL. The p1 50Glued component of the dynactin complex binds to both microtubules and the actin-related protein centractin (Arp-1 ). Proc Natl Acad Sci USA 1995;92:1634-1638.
257. 257. Lees-Miller JP, Helfman DM, Schroer TA. A vertebrate actin-related protein is a component of a multisubunit complex involved in microtubule-based vesicle motility. Nature 1992;359:244-246.
258. 258. Schafer DA, Gill SR, Cooper JA, Heuser JE, Schroer TA. Ultrastructural analyses of the dynactin complex: an actin-related protein is a component of a filament that resembles F-actin. J Cell Biol 1994;126:403-412.
259. 259. Holleran EA, Tokito, MK, Karki S, Holzbaur EL. Centractin (ARP1) associates with spectrin revealing a potential mechanism to link dynactin to intracellular organelles. J Cell Biol 1996;135:1815-1829.
260. 260. Allan V. Motor proteins: a dynamic duo. Curr Biol 1996;6:630-633.
261. 261. Echeverri CJ, Paschal BM, Vaughan KT, Vallee RB. Molecular characterization of the 50-kD subunit of dynactin reveals function for the complex in chromosome alignment and spindle organization during mitosis. J Cell Biol 1998;132:617-633.
262. 262. Burkhardt JK, Echeverri CJ, Nilsson T, Vallee RB. Overexpression of the dynamitin (p50) subunit of the dynactin complex disrupts dynein-dependent maintenance of membrane organelle distribution. J Cell Biol 1997;139:469-484.
263. 263. Harada A, Takei Y, Kanai Y, Tanaka Y, Nonaka S, Hirokawa N. Golgi vesiculation and lysosome dispersion in cells lacking cytoplasmic dynein. J Cell Biol 1998;141:51-59.
264. 264. Bomsel M, Parton R, Kuznetsov SA, Schroer TA, Gruenberg J. Microtubule-and motor-dependent fusion in vitro between apical and basolateral endocytic vesicles from MDCK cells. Cell 1990;62:719-731.
265. 265. Aniento F, Emans N, Griffiths G, Gruenberg J. Cytoplasmic dynein-dependent vesicular transport from early to late endosomes. J Cell Biol 1993;123:1373-1387.
266. 266. Rogers SL, Tint IS, Fanapour PC, Gelfand VI. Regulated bidirectional motility of melanophore pigment granules along microtubules in vitro. Proc Natl Acad Sci USA 1997;94:3720-3725.
267. 267. Presley JF, Cole NB, Schroer TA, Hirschberg K, Zaal KJ, Lippincott-Schwartz J. ER-to-Golgi transport visualized in living cells. Nature 1997;389:81-85.
268. 268. Kumar J, Yu H, Sheetz MP. Kinectin, an essential anchor for kinesin-driven vesicle motility. Science 1995;267:1834-1837.
269. 269. Vale RD, Malik F, Brown D. Directional instability of microtubule transport in the presence of kinesin and dynein, two opposite polarity motor proteins. J Cell Biol 1992;119:1589-1596.
270. 270. Yu H, Toyoshima I, Steuer ER, Sheetz MP. Kinesin and cytoplasmic dynein binding to brain microsomes. J Biol Chem 1992;267:20457-20464.
271. 271. Lin SX, Pfister KK, Collins CA. Comparison of the intracellular distribution of cytoplasmic dynein and kinesin in cultured cells: motor protein location does not reliably predict function. Cell Motil Cytoskeleton 1996;34:299-312.
272. 272. Wang Z, Khan S, Sheetz MP. Single cytoplasmic dynein molecule movements: characterization and comparison with kinesin. Biophys J 1995;69:2011-2023.
273. 273. Kuo SC, Gelles J, Steuer E, Sheetz MP. A model for kinesin movement from nanometer-level movements of kinesin and cytoplasmic dynein and force measurements. J Cell Sci 1991;14 (Suppl):135-138.
274. 274. Matteoni R, Kreis TE. Translocation and clustering of endosomes and lysosomes depends on microtubules. J Cell Biol 1998;105:1253-1265.
275. 275. Herman B, Albertini DF. A time-lapse video image intensification analysis of cytoplasmic organelle movements during endosome translocation. J Cell Biol 1984;98:565-576.
276. 276. Schnapp BJ, Vale RD, Sheetz MP, Reese TS. Single microtubules from squid axoplasm support bidirectional movement of organelles. Cell 1985;40:455-462.
277. 277. Lee KD, Hollenbeck PJ. Phosphorylation of kinesin in vivo correlates with organelle association and neurite outgrowth. J Biol Chem 1995;270:5600-5605.
278. 278. Lindesmith L, McIlvain JM Jr, Argon Y, Sheetz MP. Phosphotransferases associated with the regulation of kinesin motor activity. J Biol Chem 1997;272:22929-22933.
279. 279. Matthies HJ, Miller RJ, Falfrey HC. Calmodulin binding to and cAMP-dependent phosphorylation of kinesin light chains modulate kinesin ATPase activity. J Biol Chem 1993;268:11176-11187.
280. 280. Sato-Yoshitake R, Yorifuji H, Inagaki M, Hirokawa N. The phosphorylation of kinesin regulates its binding to synaptic vesicles. J Biol Chem 1992;267:23930-23936.
281. 281. Hollenbeck PJ. Phosphorylation of neuronal kinesin heavy and light chains in vivo. J Neurochem 1993;60:2265-2275.
282. 282. Lin SX, Ferro KL, Collins CA. Cytoplasmic dynein undergoes intracellular redistribution concomitant with phosphorylation of the heavy chain in response to serum starvation and okadaic acid. J Cell Biol 1994;127:1009-1019.
283. 283. Rothwell SW, Calvert VS. Activation of human platelets causes post-translational modifications to cytoplasmic dynein. Thromb Haemost 1997;78:910-918.
284. 284. Farshori P, Holzbaur EL. Dynactin phosphorylation is modulated in response to cellular effectors. Biochem Biophys Res Comm 1997;232:810-816.
285. 285. Niclas J, Allan VJ, Vale RD. Cell cycle regulation of dynein-association with membranes modulates microtubule-based organelle transport. J Cell Biol 1996;133:585-593.
286. 286. Blangy A, Arnaud L, Nigg EA. Phosphorylation by p34cdc2 protein kinase regulates binding of the kinesin-related motor HsEg5 to the dynactin subunit p150. J Biol Chem 1997;272:19418-19424.
287. 287. Wubbolts R, Fernandez-Borja M, Jordens I, Dusseljee S, Neefjes J. Opposing motor activities of kinesin and dynein mediate bi-directional transport of MHC class II containing vesicles. J Cell Sci 1998;112:785-795.
288. 288. Van Ham SM, et al. HLA-DO is a negative modulator og HLA-DM-mediated MHC class II peptide loading. Curr Biol 1997;7:950-957.
289. 289. Wang K, Peterson PA, Karlsson L. Decreased endosomal delivery of major histocompatibility complex class II-invariant chain complexes in dynamin-deficient cells. J Biol Chem 1997;272:17055-17060.
290. 290. Steyer JA, Horstmann H, Almers W. Transport, docking and exocytosis of single secretory granules in live chromaffin cells. Nature 1997;388:474-478.
291. 291. Plattner H, Artalejo AR, Neher E. Ultrastructural organization of bovine chromaffin cell cortex-analysis by cryofixation and morphology aspects pertinent to exocytosis. J Cell Biol 1997;139:1709-1717.
292. 292. Rothman JE, Wieland FT. Protein sorting by transport vesicles. Science 1996;272:227-234.
293. 2+-regulated exocytosis. J Cell Biol 1997;138:999-1008.
294. 294. Aunis D, Bader MF. The cytoskeleton as a barrier to exocytosis in secretory cells. J Exp Biol 1988;139:253-266.
295. 295. Muallem S, et al. Actin filament disassembly is a sufficient final trigger for exocytosis in nonexcitable cells. Mechanism of action of Clostridium difficile toxin B: role of external medium and cytoskeletal organization in intoxicated cells. J Cell Biol 1995;128:589-598.
296. 296. Durrbach A, Louvard D, Coudrier E. Actin filaments facilitate two steps in endocytosis. J Cell Sci 1996;109:457-465.
297. 297. Johnston GC, Prendergast JA, Singer RA. The Saccharomyces cerevisiae MYO2 gene encodes an essential myosin for vectorial transport of vesicles. J Cell Biol 1991;113:539-551.
298. 298. Govindan B, Bowser R, Novick P. The role of Myo2, a yeast class V myosin, in vesicular transport. J Cell Biol 1995;128:1055-1068.
299. 299. Lillie SH, Brown SS. Suppression of a myosin defect by a kinesin-related gene. Nature 1992;356:358-361.
300. 300. Lillie SH, Brown SS. Immunofluorescence localization of the unconventional myosin, Myo2p, and the putative kinesin-related protein, Smy1p, to the same regions of polarized growth in Saccharomyces cerevisiae. J Cell Biol 1994;125:825-842.
301. 301. Lillie SH, Brown SS. Smy1p, a kinesin-related molecule that does not require microtubules. J Cell Biol 1998;140:873-883.
302. 302. Larson RE. Myosin-V: a class of unconventional molecular motors. Braz J Med Biol Res 1996;29:309-318.
303. 303. Rodionov VI, Hope AJ, Svitkina TM, Borisy GG. Functional coordination of microtubule-based and actin-based motility in melanophores. Curr Biol 1998;8:165-168.
304. 304. Rogers SL, Gelfand VI. Myosin cooperates with microtubule motors during organelle transport in melanophores. Curr Biol 1998;8:161-164.
305. 305. Cheney RE, et al. Brain myosin V is a two-headed unconventional myosin with motor activity. Cell 1993;75:13-23.
306. 306. Mermall V, Post PL, Mooseker MS. Unconventional myosins in cell movement, membrane traffic and signal transduction. Science 1998;279:527-533.
307. 307. Titus MA. Motor proteins: myosin V - the multi-purpose transport motor. Curr Biol 1997;7: R301-R304.
308. 2+-dependent interaction with the synaptobrevin-synaptophysin complex. J Cell Biol 1997;137:1589-1601.
309. 309. Nascimento AA, Amaral RG, Bizario JC, Larson RE, Espreafico EM. Subcellular localization of myosin-V in the B16 melanoma cells, a wild-type cell line for the dilute gene. Mol Biol Cell 1997;8:1971-1988.
310. 310. Benashski SE, Harrison A, Patel-King RS, King SM. Dimerization of the highly conserved light chain shared by dynein and myosin V. J Biol Chem 1997;272:20929-20935.
311. 311. Ploegh HL. Viral strategies of immune evasion Science 1998;280:248-253.
312. 312. Cossart P, Boquet P, Normark S, Rappuoli R. Cellular microbiology emerging Science 1996;271:315-316.